about
Systemic Treatment of Pediatric Psoriasis: A ReviewHidradenitis suppurativa: from pathogenesis to diagnosis and treatmentEffects of climate changes on skin diseases.The effect of smartphone addiction on hand joints in psoriatic patients: an ultrasound-based study.Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist.Primary bilateral malignant melanoma of the lower limbs.Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation.The risk of herpes zoster in the anti-TNF-α era: a case report and review of the literature.Systemic Treatment of Adult Atopic Dermatitis: A Review.Anterior cervical hypertrichosis: a case report and review of the literature."Active" photoprotection: sunscreens with DNA repair enzymes.Psoriatic arthritis and psoriasis: differential diagnosis.Waste exposure and skin diseases.The role of histological presentation in erythroderma.Anti-Tumor Necrosis Factor-α Therapy in the Management of Psoriasis and B-Chronic Lymphocytic Leukemia.Psoriasis in melanoma patients: a prospective pilot study.Garbage and skin diseases related risk.Melanocytic nevi in children of southern Italy: dermoscopic, constitutional, and environmental factors.The risk of herpes zoster in patients with psoriasis: A retrospective records-based observational study.Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis.Systemic treatment for psoriasis and malignancies: A real risk?Psoriasis and sport: a new ally?The effects of etanercept on replication, proliferation, survival, and apoptosis markers in moderate to severe psoriasis.Hailey-Hailey disease successfully treated with vitamin D oral supplementationAcne prevalence in 9 to 14-year-old old patients attending pediatric ambulatory clinics in ItalyPsoriasis in a cohort of patients with common variable immunodeficiencyCoffee consumption, metabolic syndrome and clinical severity of psoriasis: good or bad stuff?Psoriasis and Skin Pain: Instrumental and Biological EvaluationsMeyerson Phenomenon Around Naevi: Resolution After Sun Exposure?Efficacy and safety of ustekinumab in a group of 22 elderly patients with psoriasis over a 2-year period.Patient-physician relationship in patients with psoriasisMinimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world studySoccer helps in controlling the development of psoriasis in Italian second league playersAdult Atopic Dermatitis: Less Certainty, More ChallengesReal-life effectiveness of biological drugs on psoriatic difficult-to-treat body regions: scalp, palmoplantar area and lower limbsAge and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patientsA case of severe psoriasis in a 84-year-old women successfully treated with ixekizumabSecukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world studyCutaneous melanoma associated with naevi prevalence: A 15-year cross-sectional retrospective studyA case of pediatric acrodermatitis continua of Hallopeau successfully treated with adalimumab biosimilar
P50
Q26753026-4597AC86-F4B1-4CA8-8A8E-E908D468EEC6Q30234599-0A6FB7AC-93BD-4EEF-BD5F-0EE060AAF860Q30729680-DCC6061B-0608-4429-831E-D44B91E9D16BQ33454808-74473B92-85E1-4BB6-AED3-ED8FDC9D926AQ33841808-FF06159C-8547-42C3-AA80-1E3B1220A6ABQ34413938-42567731-A11B-438E-9E10-09D00A79BD86Q35716177-DC6A1F3E-F2D4-4696-B9D0-B45195B981BFQ36755236-C6FE9819-E06F-43CD-B3DE-3321635562CCQ37679948-799109EB-DEB1-4781-AFBA-4E6F4F9A27A1Q38219275-F0108488-7C0A-4074-85C0-616F39FB6331Q38756451-098956CE-D535-4A19-8B53-AB26842CA019Q38828427-DB44DE26-0F96-409D-B9A5-9894E6D109DEQ38956801-7D9624C3-A474-47B9-8655-00DAED745AD7Q38964571-1889186B-E943-477F-9962-F968EE9A74A6Q40328041-65F688D6-BE26-4A33-B437-18A88F40B9D9Q41076268-86EBB9F2-5D4E-4825-B81C-30BBF65D5967Q43352818-3971A146-AA54-46A6-AC37-24B9640FACCDQ43902698-8280C620-22AA-4793-A7BB-64368FC293F7Q44897757-F9B92D32-7E3B-4504-91F6-FB86E0296718Q47933155-A1BF2BB5-DD17-4DFD-8E15-E91D0297CD7AQ48218718-7A9B6AC1-2D48-4D03-8275-334D4D571532Q51800505-367BAB3E-056B-429F-899F-918FC58E8AFAQ53196738-8D7F3656-9BED-4848-A8D7-E9350164BAF6Q57021567-B0BE5E2F-2967-41CC-BA9A-5C52278628B5Q57129764-0009C583-396D-4E36-BFBA-12D710BBB918Q58555553-A6A37073-1362-49F6-9E3D-10BB05214E1BQ59238017-EC8730B8-DD75-4714-8A4E-AA549EF22F19Q60607930-FE4CA312-EC8A-4295-82CA-74F8A8C8A5C7Q60607946-6433FF66-8A00-4C07-8495-851DD580430FQ64935315-E160FA7F-8840-4E12-9B7C-403C7CE64384Q83663187-861D9270-F5C0-478B-A550-EDCA5EFF07D5Q88205381-BDEC9BBF-17C0-440D-8477-CAC6EA2F9834Q88340187-76E5B94C-13CA-412E-A45D-9684DFBCA126Q88574950-C9A70BDC-E1DB-4205-AB3A-CBF524F927E6Q89058469-6F4C064F-4E2F-472D-9C57-6D8D77EEBB15Q90175895-CBC7EBD6-1D4E-4EFA-A74D-92361EFABCA0Q90213072-2978E934-FACD-4DBB-8234-27D32CD26EA1Q90304956-CBA8F69C-5F43-452C-84BA-7ACB35BB1D20Q90653011-B97C2B3F-AE53-459C-BAB2-5C7871DA5A6BQ90706654-958B349E-D0EE-479D-ADDB-475D9325AC32
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1803-2046
@en
name
Matteo Megna
@ast
Matteo Megna
@en
Matteo Megna
@es
Matteo Megna
@nl
type
label
Matteo Megna
@ast
Matteo Megna
@en
Matteo Megna
@es
Matteo Megna
@nl
prefLabel
Matteo Megna
@ast
Matteo Megna
@en
Matteo Megna
@es
Matteo Megna
@nl
P106
P1153
37120906800
P31
P496
0000-0003-1803-2046